Search - tctmd.com

Displaying 81 - 100 of 259

Sort: Relevancy | Date

Presentation TCT 2017

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Presenter: Julinda Mehilli, Giulio G. Stefanini, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Trial In the Pocket: Myheartcounts

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Alan C. Yeung

October 30, 2017

Presentation TCT 2017

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Jacqueline Saw

October 30, 2017

Presentation TCT 2017

Making the EHR Useful For Research: ADAPTABLE

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran, Adrian F Hernandez

October 30, 2017

Presentation TCT 2017

Keeping It Simple: Large Pragmatic Trials

Presenter: Ori Ben-Yehuda, Robert A. Harrington, Roxana Mehran

October 30, 2017

Presentation TCT 2017

Case Presentation: DCB in a De Novo Lesion

Presenter: Roxana Mehran, Bo Xu, Jun Jiang

October 29, 2017

Presentation TCT 2017

Current Practice and Perspectives on DCB in China

Presenter: Roxana Mehran, Bo Xu, YunDai Chen

October 29, 2017

Presentation TCT 2017

Case Presentation: Implantation of BRS With Imaging Follow-up

Presenter: Roxana Mehran, Bo Xu, Lei Song

October 29, 2017

Presentation TCT 2017

Clinical Trial Updates of BRS in China

Presenter: Roxana Mehran, Bo Xu, Kai Xu

October 29, 2017

Presentation SCAI 2017

Long-term outcomes of Bioresorbable Vascular Scaffolds

Presenter: Roxana Mehran

May 13, 2017

Presentation JIM 2017

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Presenter: Roxana Mehran

February 10, 2017

Presentation TCT 2016

Case Conclusion: How Did We Treat Our Patient?

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Dominick J. Angiolillo

November 01, 2016

Presentation TCT 2016

To Pretreat or Not to Pretreat? The DUBIUS Trial

Presenter: Roxana Mehran, Ferdinando Varbella, Giuseppe Tarantini

November 01, 2016

Presentation TCT 2016

Case Introduction: An Elderly Patient With NSTE-ACS

Presenter: Roxana Mehran, Ferdinando Varbella, Alberto Menozzi

November 01, 2016

Presentation TCT 2016

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

Presenter: Freek W.A. Verheugt, Pascal Vranckx, Roxana Mehran

November 01, 2016

Presentation TCT 2016

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Presenter: David P. Faxon, C. Michael Gibson, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Contrast Reduction Strategies in the Patient With CKD

Presenter: Somjot S. Brar, Richard Solomon, Roxana Mehran

November 01, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

Presenter: Deepak L. Bhatt, Roxana Mehran, Michael S. Lauer

October 31, 2016

Presentation TCT 2016

Pragmatic Simple Trials and Big Data: Advantages and Caveats

Presenter: Deepak L. Bhatt, Roxana Mehran, Robert A. Harrington

October 31, 2016

Advertisement

Outcomes With the Stentys Self-Expanding DES in STEMI and Other Clinical Scenarios

Trial In the Pocket: Myheartcounts

Facebook and Twitter for Trial Recruitment: SCAD Case Example

Making the EHR Useful For Research: ADAPTABLE

Keeping It Simple: Large Pragmatic Trials

Case Presentation: DCB in a De Novo Lesion

Current Practice and Perspectives on DCB in China

Case Presentation: Implantation of BRS With Imaging Follow-up

Clinical Trial Updates of BRS in China

Long-term outcomes of Bioresorbable Vascular Scaffolds

The Future of Long Term Antiplatelet therapy: Is life Long Aspirin Still Necessary?

Case Conclusion: How Did We Treat Our Patient?

Intravenous P2Y12 Receptor Inhibitors Transitioning to a Potent Oral Anti-platelet Agent if PCI Is Performed Is Optimal Treatment in NSTE-ACS

To Pretreat or Not to Pretreat? The DUBIUS Trial

Case Introduction: An Elderly Patient With NSTE-ACS

The AUGUSTUS Trial: Apixaban in Patients With Atrial Fibrillation and ACS/PCI: Design, Rationale, and Status

When and Which Antiplatelet Agent Should be Dropped When Using Oral Anticoagulant Therapy?

Contrast Reduction Strategies in the Patient With CKD

Pragmatic Simple Trials and Big Data: Implications for NIH Funding

Pragmatic Simple Trials and Big Data: Advantages and Caveats

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content